Small Cell Lung Cancer
Author and Disclosure Information [Show]

Hirva Mamdani, MD
Assistant Professor of Medicine and Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI

Shadia I. Jalal, MD
Associate Professor of Medicine, Indiana School of Medicine, Indiana University Simon Cancer Center, Indianapolis, IN

Read the full article Small Cell Lung Cancer.

Question 1 of 6

A 65-year-old man presents to the emergency department with worsening shortness of breath and cough over the past 2 months. He has also had a 15-lb weight gain over the same period. He has smoked 2 packs of cigarettes daily for the past 30 years. His physical examination is remarkable for an obese man with bilateral supraclavicular fullness and a blood pressure of 200/120 mm Hg. Imaging studies reveal a 5-cm left hilar mass with an enlarged subcarinal lymph node. His laboratory studies show normal complete blood count (CBC) and comprehensive metabolic panel (CMP) except for a serum sodium concentration of 150 mEq/L (reference range: 136–142 mEq/L), serum potassium of 2.9 mEq/L (reference range: 3.5–5.0 mEq/L), and serum bicarbonate of 32 mEq/L (reference range: 21–28 mEq/L). He is admitted to the hospital for further workup. Bronchoscopy with endobronchial ultrasound for transbronchial biopsy of the left hilar mass and subcarinal lymph node is performed. The preliminary result of the biopsy is consistent with malignancy.

The malignant cells are most likely to be positive for which of the following immunohistochemical stains?

CDX2

Chromogranin A

CK20

CD30

PLAP (placental alkaline phosphatase)

Hospital Physician: Hematology/Oncology. 2018 October;13(5)

This quiz is not accredited for CME.

More from Board Review Questions: Hematology/Oncology

QUIZ

Management of Metastatic Gastric Cancer
Transfusion Medicine
Management of Colorectal Cancer in Older Adults
Urothelial Carcinoma: Muscle-Invasive and Metastatic Disease
Acute Myeloid Leukemia
Pancreatic Adenocarcinoma: Advanced Unresectable and Metastatic Disease
HER2-Positive Breast Cancer
Aggressive B-Cell Non-Hodgkin Lymphoma
Von Willebrand Disease: Assessment and Diagnostic Testing
Von Willebrand Disease: Clinical Management
Pancreatic Adenocarcinoma: Neoadjuvant and Adjuvant Treatment
Late Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Polycythemia Vera and Essential Thrombocythemia: Current Management
Treatment of Biliary Tract Cancers
Early Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Hairy Cell Leukemia
Genomic Testing in Women with Early-Stage Hormone Receptor–Positive, HER2-Negative Breast Cancer
Immune Thrombocytopenia
Cancer-Related Fatigue
Disseminated Intravascular Coagulation
Advanced Stage and Relapsed/Refractory Hodgkin Lymphoma
Adjuvant Chemotherapy for Colon Cancer
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer
Metastatic Cutaneous Melanoma: Targeted Therapy and Immunotherapy
Thrombosis in Pregnancy
Locally Advanced Pancreatic Cancer
Early-Stage Hodgkin Lymphoma
Neoadjuvant and Adjuvant Therapy for Gastric Cancer
Hemophilia A and B
Mantle Cell Lymphoma
Soft Tissue Sarcoma
Sickle Cell Disease
Renal Cell Carcinoma
Management of Locally Advanced Rectal Adenocarcinoma
Adjuvant Systemic Therapy for Early-Stage Breast Cancer
Chronic Myeloid Leukemia
Plasma Cell Disorders
Myelodysplastic Syndromes
Acute and Chronic Graft-versus-Host Disease